propiolactone has been researched along with Coxsackie Virus Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Y; Huang, X; Huang, Z; Ku, Z; Li, D; Liu, Q; Zhang, Y | 1 |
Chao Zhang, Y; Guo Su, Z; Li, Q; Ping Yang, B; Qi An, W; Shi, L; Wen Pan, R | 1 |
2 other study(ies) available for propiolactone and Coxsackie Virus Infections
Article | Year |
---|---|
Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Chlorocebus aethiops; Coxsackievirus Infections; Disease Models, Animal; Enterovirus; Female; Immunization, Passive; Interferon-gamma; Mice; Mice, Inbred ICR; Neutralization Tests; Propiolactone; T-Lymphocytes; Vaccination; Vaccines, Inactivated; Vero Cells; Viral Vaccines | 2013 |
The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems.
Topics: Animals; Antibodies, Viral; Coxsackievirus Infections; Disinfectants; Dose-Response Relationship, Immunologic; Enterovirus; Female; Immunity, Maternally-Acquired; Immunization, Passive; Lethal Dose 50; Macaca fascicularis; Mice, Inbred BALB C; Propiolactone; Rats, Sprague-Dawley; Survival Analysis; Vaccines, Inactivated; Viral Vaccines; Virus Inactivation | 2014 |